Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 08 Sep 2020 |
2 | Reply to Exam Report (MIS-R) | 06 Sep 2021 |
3 | Journal Copy | 18 May 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 13 Jun 2022 |
5 | Annexure -1 under rule 46 | 05 Sep 2023 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 05 Sep 2023 |
6 | Annexure -1 under rule 46 | 05 Sep 2023 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 05 Sep 2023 |
1 | Hearing Notice (Show Cause) | 12675332 | 20 Dec 2021 | |
2 | Tribunal Accepted Notice for : 4646522 | 13057465 | 5505592 | 21 Feb 2022 |
3 | Opposition Notice | 15044035 | 5911091 | 31 Mar 2023 |
4 | Opposition Counter Statement | 15977438 | 6175406 | 06 Sep 2023 |
The application for Delaza was made on 08 September 2020.
The trademark applicant for Delaza is SUN PHARMA LABORATORIES.
Delaza is applied in class(es) 5.
Application for Delaza is on Opposed stage.
Application Id allotted to Delaza is 4646522.
Delaza filed with the Intellectual property office as a WORD.